Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment.

Hsin-Pai LiChen-Yang HuangKar-Wai LuiYin Kai ChaoChun-Nan YehLi-Yu LeeYenlin HuangTung-Liang LinYung-Chia KuoMei-Yuan HuangYi-Ru LaiYuan-Ming YehHsien-Chi FanAn-Chi LinJason Chia-Hsun HsiehKai-Ping ChangChien-Yu LinHung-Ming WangYu-Sun ChangCheng-Lung Hsu

Published in: Cancers (2021)

Our results provide encouraging preliminary data related to the combination treatment of EGFRi and palbociclib in patients with NPC.

Keyphrases

growth factor
electronic health record
cell cycle
cell proliferation
replacement therapy